LDX Discussion, page-1064

Unsubstantiate this.
Some posters on here understand the basic principles of business. But what these other posters understand is that up until the last 12 months, the company was reliant on the core product being available and taken up in other regions such as the UK. (1) The product has been available in the UK for over 3 years now with minimal uptake (why? lack of process within the system? (2) Not correct as a new Pharmacy process was established which Febridx was provided under, literally avoiding the GP office visits.). If the company had no clear idea whether the FDA would approved Febridx or not (several failed attempts, they should have been focusing efforts on the other regions to ensure global uptake was occurring. (Refer to point 1 again. The FDA approval in March 2023 was pre submission with no guarantee of success.

1. Quarterly Report March 2023:





In fact, if you review the history of Febridx, the device design changed from its original design to provide better use and simplicity for FDA approval.

2. UK New system:



https://pharmatimes.com/news/liverpool_ccg_and_community_pharmacy_liverpool_launch_febridx_point-of-care_test_1386157/

Now they have FDA approval, the chatter has changed to focussing on the US market for good reason, its a bigger market. However doesn't answer the previous question - why wasn't the company doing more in the regions which approved the product sooner?

Why do we want this to be in Australia? Simple, for visibility on the product and more local awareness of what the company does, to improve shareholder value and growth in the SP via other local investors taking positions. The other benefit is that with Australia's universal Medicare system, we have process and systems in place to already reimburse for these costs along side private health insurance also. If Febridx was listed on the MBS, the cost to patient would be minimal and uptake of the

Its not that people on here don't understand they benefits of US business. Maybe people want to see existing regions supported to grow also?

300Million people in the USA with a TAM of $1.7Billion.

Just for clarity, the total population of the other regions LDX is in is 273Million (3)

3. Population estimates: